Biota Biosciences announced the voluntary recall of CBD Complex, Curcumin Complex, and Cannabidiol + Curcumin Injectables due to the products being marketed without the approval of the FDA.
Metabolic syndrome factors and modifiable lifestyle habits are associated with prevalence of diabetic polyneuropathy and neuropathic pain.
The management of painful diabetic peripheral neuropathy requires the use of effective agents that also may aid in improving sleep and mood.
Researchers to explore the somatosensory changes related to trigeminal nerve damage using psychophysical and electrophysiological tools.
Researchers compared the health-related quality of life in patients with Sjögren syndrome, with and without peripheral neuropathy.
Several cardiac and kidney biomarkers may be used to identify older adults with peripheral neuropathy.
The FDA has granted Fast Track designation to vutrisiran (Alnylam) for the treatment of the polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis in adults.
Abnormally rapid corneal nerve fiber loss may indicate increased risk for the development and progression of diabetic distal symmetric polyneuropathy.
Combination of bendamustine with rituximab treatment may be an effective regimen for immune-mediated neuropathies associated with hematologic malignancy.
Researchers determined the risk for Guillain-Barré Syndrome following seasonal influenza vaccination in a real-world study.